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Concepts of illicit drug quality among darknet market users: 
purity, embodied experience, craft and chemical knowledge  
Keywords: 
Darknet, drug quality, purity, potency, knowledge 
Abstract: 
Background  
Users of darknet markets refer to product quality as one of the motivations for 
buying drugs there, and vendors present quality as a selling point. However what 
users understand by quality and how they evaluate it is not clear. This paper 
investigates how users established and compared drug quality.  
Methods 
We used a two-stage method for investigating users' assessments. The user 
forum of a darknet market that we called 'Merkat' was analysed to develop 
emergent themes. Qualitative interviews with darknet users were conducted, 
then forum data was analysed again.  To enhance the applicability of the findings, 
the forum was sampled for users who presented as dependent as well as 
recreational. 
Results 
Quality could mean reliability, purity, potency, and predictability of effect.  We 
focused on the different kinds of knowledge users drew on to assess quality. 
These were: embodied; craft; and chemical.  
Conclusion. 
Users’ evaluations of quality depended on their experience, the purpose of use, 
and its context.  Market forums are a case of indigenous harm reduction where 




 We investigate how darknet market users assess drug quality 
 Market forums allow users to apply embodied, craft and chemical 
knowledge to compare the quality of different products 
 Good quality does not necessarily equate to high chemical purity 
 Different drugs are assessed with different priorities in mind 
 Expanding the range of knowledge types that users apply to product 
quality may have positive implications for harm reduction  
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The existence of online darknet markets for the sale of illegal products and 
services - mainly controlled drugs - has attracted attention and commentary 
since the creation of the Silk Road marketplace in 2011.  Darknet markets or 
‘cryptomarkets’ are accessed using systems that route internet traffic through a 
set of relays. These disguise where that traffic originates and goes to and can also 
encrypt it to make it resistant to interception. ‘Tor’ (The Onion Router) is the 
most popular at the time of writing but ‘i2p’ (The Invisible Internet Project) and 
‘Freenet’ are also used.  Market administrators, vendors and buyers are therefore 
not easily traceable. Users may create further layers of anonymity such as 
employing the Tails (The Amnesiac Incognito Live System) operating system and 
associated encrypted communication systems such as PGP (Pretty Good Privacy). 
Transactions are conducted using peer-to-peer currencies such as Bitcoin, 
Litecoin, Dogecoin and Darkcoin, which can permit anonymous transactions to 
be recorded. Bitcoin was the only currency employed in our study. Market 
transactions often have a laundering or ‘tumbling’ process for the currency in 
order to put distance between the user’s real identity and darknet accounts. 
Their current importance should not be overplayed. Their revenue is a small 
proportion of the illicit economy, and there are many other ways of acquiring 
drugs using the internet (Meyers et al., 2015; Race, 2015). However, their rapid 
rise to prominence, novel form of organisation, emphasis on choice and customer 
feedback, and use of encryption technology, make them a topic of interest as a 
new context of drug use (Duff, 2007).  
Research on the darknet has identified an emerging set of dispositions and 
practices that consciously reject the risks and vagaries of offline markets and 
encourage savvy, reflexive consumption (Van Hout & Bingham, 2014). Quality, 
predictability, reliability and safety are often referenced as reasons drug users 
and vendors purchase and sell on the darknet as opposed to offline or ‘street’ 
markets (Van Hout & Bingham, 2013a, 2014). They enable drug user identities 
that emphasise calculated hedonism and connoisseurship, the selection and 
comparison of different products, and elaboration of the precise effects with in-
depth trip reports (Riley, Thompson, & Griffin, 2010; Van Hout & Bingham, 
2013b). Reflecting that orientation, Silk Road users primarily bought MDMA, 2-C 
drugs, cannabis, and LSD (Barratt, Ferris, & Winstock, 2014). As noted in our 
own study, darknet markets have evolved since Silk Road's closure to sell many 
more types of drugs, with expanded listings for pharmaceuticals and opioids. We 
wanted to see how these associations of cryptomarkets facilitating 
connoisseurship applied to a wider range of drug users, including users of drugs 
typically represented as dependent, and those who present themselves as 
dependent. 
This paper explores the kinds of knowledge darknet users evaluate and bring to 
bear in assessing product quality, by which we mean the characteristics that 
make the drug effective for the user. Our perspective is that drug users and 
dealers are producers of knowledge and expertise (Jauffret-Roustide, 2009).  
Following that we treat quality as a characteristic generated in the interaction 
between the user and the drug, rather an attribute of the chemical substance that 
can be evaluated independent of the user’s subject position. Our focus is the way 
users orient themselves through the use and sharing of knowledge about 
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product quality. This can happen in a variety of ways: through the formal 
product evaluation mechanism built into sellers’ listings, via the associated 
discussion forums, in related open internet forums such as comment threads on 
the reddit community, and in buyers’ personal discussions with other users. This 
can be used to investigate users’ priorities in using the markets, the benefits they 
seek through their drug use, and their assessment of risks.  
We have used the term ‘offline’ to represent the various ways of acquiring drugs 
that do not involve the internet. The term covers deals done in private settings 
and in open-air street markets. These are very different settings. As we will 
show, ‘street’ was a usually negative term used by many users for the offline 
markets and we have used it to represent the distinction they were drawing 
between markets. However, we do not intend to suggest that offline markets are 
typically unreliable, which is far from the case. Respondents to one survey gave 
the adequate local supply as a reason for not purchasing from Silk Road (Barratt 
et al., 2014). For both on- and offline markets reliability must be produced by the 
actions of those involved (Sandberg, 2012).  Online markets are also not distinct 
from the offline. Instead, they combine in novel ways. Users combine both 
sources in their drug purchasing. Product for offline resale is purchased on the 
darknet, and dealers use it for business to business deals (Aldridge & Décary-
Hétu, 2014). The existence of cryptomarkets and other online sources do, 
however, potentially affect the overall market structure.  An example of this 
would be the shortening of supply chains (J. Martin, 2014).  
Drug quality is a subject about which there is considerable uncertainty (Evrard, 
Legleye, & Cadet-Taïrou, 2010; Reuter & Caulkins, 2004). Research involving 
users who purchase in offline settings indicates that they are often unsure of 
how to assess the quality of purchased drugs and how to ensure consistent and 
predictable quality. They are often reluctant to question drug dealers about 
quality and in the main do not see dealers as a reliable source of information 
about it (Best et al., 2004).  We cannot assume that dealers have perfect 
information on the quality of their product either. For dealers in offline markets, 
quality is difficult to demonstrate and the opportunities for price signalling are 
limited (Reuter and Caulkins, 2004). To some extent, the orientation to quality 
adopted by the user reflects the power they have in relation to the market and 
the opportunities for information sharing  (Mars et al., 2015). In cases where 
users have greater choice and opportunity to obtain drugs from different sources 
and compare experiences they are able to be more evaluative of product quality. 
For example, cannabis grower-consumers are highly critical of quality available 
in the market (Decorte, 2011) and information about quality is distributed and 
compared through cannabis social clubs (Decorte, 2015). Despite this, like the 
wider population, dealers and users share myths about quality and adulteration, 
such as that drugs are regularly cut with harmful substances (Cole et al., 2011; 
Coomber, 2011; Decorte, 2011).  
There is growing use of various online platforms through which shared 
narratives are generated to frame effective ways of using, experiencing and 
evaluating drugs (Rosino & Linders, 2015). They have the potential to contribute 
to peer harm reduction through expanding the range, depth and diversity of 
users’ interactions with peers (Van Hout, 2015; Van Hout & Hearne, 2015). 
Darknet drug markets are a particularly interesting case for exploring users’ 
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assessments of quality. Offline markets rely on repeated transactions, shared 
culture and some sharing of market intelligence on product quality where 
possible (Dwyer & Moore, 2010). Cryptomarkets must find other ways to ensure 
transactions happen. Vendors make claims about the various qualities of their 
products to which users compare their own evaluations (Buxton & Bingham, 
2015). Users are encouraged to rate the product and discuss their qualities, 
effects, and techniques of production and use with other users and vendors. An 
assumption found in much of the justificatory commentary on darknet markets is 
that they make the problem of quality transparent. For example, a group called 
The LSD Avengers tested the purity of LSD purchased on the Silk Road and posted 
the results on the market forum.  
It is implicitly assumed that quality equates to chemical purity. Though part of 
the equation, this approach tends to present each drug as an entity with singular 
effects tied to its inherent chemical nature (Dwyer & Moore, 2013). We find it 
more productive to treat the drug as an unstable object that is generated in the 
practical application of knowledge and technique by producers, distributors and 
users (Gomart, 2002). That fact is implicitly recognised in users’ own practice 
and discourse (Dwyer, 2008; Moore & Measham, 2008). Users discuss, share 
ideas and reflect on how to maximise desired effects (Jacinto, Duterte, Sales, & 
Murphy, 2008; Southgate & Hopwood, 2001). Emerging from this theoretical 
stance, we hypothesised that the use of different forms of knowledge were key in 
shaping different users’ assessments of what drug quality meant and which 
products were of better or worse quality. The knowledge used is crucial because 
it configures the drug, the user and the context of use. This configuration is a 
process of assembling knowledge about drug effects, quality, pharmacokinetics, 
the user’s body and psychology, and the setting of use into a stable, coherent 
object (Duff, 2011; Zinberg, 1984). We draw on the distinction between the raw 
and the cooked made by Claude Lévi-Strauss (1969). Users ‘cook’ in the sense 
meant by him, working on the raw substance to produce an entity that is a 
culturally meaningful, useable drug. Our perspective recognises users’ own 
agency and self-organisation in managing risk and reducing harm (Friedman et 
al., 2007). It also recognises that agency as structured and contained (Rhodes, 
2009).   
Methods 
In order to cross-check and triangulate data we used qualitative interviews and 
posts on the user forum for a darknet market that we have anonymised as 
‘Merkat’. Merkat is, at the time of writing in October 2015, one of the major 
darknet markets. It was established in late 2013 and has benefited from the law-
enforced or scam-induced closure of competitors. Merkat has an associated 
forum. The forum is broad-ranging and lively. Discussions of both vendor and 
product quality form a large part of the forum.  Research in this area involves 
developing ethical practice in a set of communities where ‘hidden’ is the norm. In 
line with good practice we attempted to contact the marketplace and forum 
organisers about our research (Barratt, 2011). We waited one month for a reply 
but did not receive one. We then decided to proceed with data collection as the 
forum is public and the forum rules did not restrict research. We chose to 
anonymise the marketplace itself as we did not have permission from the 
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administrators to identify it in published work. Although the forum is publicly 
accessible, anonymisation was in line with the norms involved in users’ 
interactions with the market, which emphasise the use of multiple anonymising 
practices (Association of Internet Researchers, 2012). Quotes from forums are 
paraphrased to ensure users cannot be identified through searching. When 
paraphrasing we preserved tone, style and meaning. We used square brackets to 
explain common phrases.  There is a loss as the original posts are not presented 
here, however we aimed to preserve the emotional and expressive tone of the 
words used. We did not post about our research on the forum as new users were 
restricted to a 'noobs' thread until 20 posts were made. We felt that posting the 
same information 20 times would have been spamming.  Approval for the study 
was received from the University of Edinburgh School of Social and Political 
Science research ethics committee. Names of interviewees and forum users are 
pseudonyms. 
Five interviewees were recruited using word of mouth during summer 2015. 
Interviews were used to explore emergent themes from the initial coding.  
Interviewees had used a variety of markets, from the original Silk Road to the 
many other darknet markets currently live, including Merkat. Interviews were 
conducted face to face, by Skype, and by encrypted chat systems.  The content of 
relevant threads was entered into the qualitative data management programme 
Nvivo and coded automatically and by hand.  The database of consisted of 152 
threads, ranging from 20 to 7,000 posts on each thread. Forum data covered the 
2 year period from its creation. We lurked in the forum from March-May 2015 
and collected the posts in May. In total 3196 text elements were coded for this 
paper. Coding was carried out until the codes exhausted the data and no new 
material had to be coded. We continued coding forum data and reviewing the 
emergent coding themes alongside interviewing. Initially, we simplistically 
interpreted ‘quality’ as a term used by forum users and interviewees to mean 
‘good’ or ‘chemically pure’. As coding went on it became apparent that to make 
assessments of quality users were employing knowledge judgements with very 
different epistemological groundings, from the experiential, based on personal 
reports of their and others experience with the drug, to positivist claims about 
chemical content.  
One advantage of research with darknet users on this topic is that forum 
discussions and interviews relate directly to specific product purchases. Vendors 
make claims about their product's quality. Users discuss various aspects of the 
drug purchased when comparing quality and forum users feed this back to their 
peers. It makes for very rich data with intricate and thoughtful reflections by 
users on their criteria for evaluating drug quality.  The forum discussions were 
especially useful in broadening the data sampling.  Our interviewees were young 
(20-25 years), male and had college degrees. They self-identified as recreational 
and weekend users for whom choice and variety is paramount in their decision 
making about drug purchases.  In the main they used psychedelics, cannabis and 
ecstasy, and described their motivations as pleasure and self-exploration. For 
them, quality tended to be an 'either/or' judgement: it was pleasurable or not. 
The forums expanded our focus to users with a wider range of social 
backgrounds, whose self descriptions indicated they were in relative poverty, or 
otherwise precarious personal situations, and some who identified as female. 
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Forums included users of heroin, other opioids, cocaine, methamphetamine and 
pharmaceuticals, and users who presented and self-identified in forums as 
dependent, referring to themselves as ‘addicts’ or ‘junkies’. This gave us an 
insight into users who seek and value very different qualities in a drug from 
recreational users, such as being able to use it while working, or to manage 
withdrawal symptoms. This division between recreational and dependent use 
was helpful in understanding the range of motivations users had in seeking out 
and assessing drug quality. However, care should be taken in applying this 
typology which can be used to stigmatise some users and de-legitimate their 
accounts (Carnwath & Smith, 2002). Many forum users who self-identified as 
dependent also reported using drugs recreationally at the same time or at 
different points in their life course, and some had moved from dependent to 
recreational use and vice versa at the time the study was conducted. 
Motivations and orientations 
As we show in this paper, quality has different meanings: it can stand for 
reliability, chemical purity, effective potency, predictability of effect, security of 
supply and financial value. Unsurprisingly for committed darknet users, they all 
agree on one point: whatever it meant, quality is expected to be reliably high in 
the darknet. We found that users have already made use of offline markets, and 
‘street quality’ is a commonly used term for the lowest quality product. As one 
interviewee explains, although it is possible to obtain good quality products in 
the offline markets, it is not possible to do so reliably or as cheaply: 
The average for stuff that is available on the darknet, and that’s for across the 
board pretty much every drug I have seen, stuff that I would never consider 
buying but I’ve seen reviews for things, that’s on par with the best things you 
can get on the street here. Best weed [cannabis] I ever had, the pills I got there 
were equivalent to, I’m not sure what the current big one is I think it’s UPS 
[ecstasy brand] are the big popular ones just now. It's equivalent to the best 
you can get on the street. So I mean, these were people already selling very 
high quality so it was about the same quality as before but they would get it 
much cheaper. 
Interviewee ‘Al’ 
Darknet markets also provide variety and the ability to select specific products 
that were not available on the local market. Users found personal enjoyment in 
making use of the darknet and developing and using their digital knowledge and 
exploring the range of different options available to them. 
There's a few reasons for why I started buying on the darknet originally. While 
I can't remember what the most important reason was back at the time, it was 
probably to do with the general quality of products that you could receive via 
the markets; certainly a lot better than what I used to get back at home (which 
is thanks to a feedback system which puts it in the seller’s best interest to 
actually sell what they claim to sell). ... While it might take some time to get 
your head around how to use it and some dedication, once you get started it 
gets easier, though its not to say that you don't run into issues every so often. 
Interviewee ‘Doc’ 
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A more general sense of personal dignity is also enjoyed as a benefit, and this 
was repeated in many forum discussions: 
I’m glad I could kind of share my experience just because when it happened I 
was so happy that it existed, and I think, as you said, it gets a bad rep. I never 
felt like I was a criminal for using it you know. I guess everyone would say that 
Interviewee ‘Sel’ 
Although they were often skilled users of the offline markets, forum users and 
interviewees prefer the more respectful, professional and less stigmatising 
interactions open to them through the darknet. They experience a developing 
sense of agency and control over their drug-buying that is harder to achieve and 
reliably maintain in offline transactions. In part, their satisfaction involves a 
‘rational consumer’ mentality that emphasises choice, variety, value and quality 
of product, and that minimises possible harm (Van Hout & Bingham, 2013b). It 
also includes the opportunity to demonstrate their own knowledge and ability in 
relation to peers and law enforcement, such as using encryption to defy police 
surveillance online and offline. These ‘seductions of crime’ (Katz, 1988) are 
subtle and take place in the satisfaction of achieving successful transactions and 
demonstrating one’s ability to interact with systems such as bitcoin, Tor and 
Tails. This sense of agency often bleeds into a libertarian, anti-interventionist 
stance regarding drug prohibition and the role of the state, sometimes 
proclaimed in the sites’ own documentation. That contrasts with attempts by law 
enforcement to portray the darknet as a harmful, criminal morass (J. Martin, 
2014). Having said that, many users and market owners are simply pragmatists 
weighing up the costs and benefits and who enjoy demonstrating their digital 
nous.  
It is notable that a rational consumer orientation is not confined to recreational 
users. Users who present themselves as dependent also employed these methods 
of evaluation.  The salience of different factors varied, however. One important 
consideration was having the right combination of heroin and opioid to avoid 
withdrawal while working: 
Mate, I have some subs [buprenorphine] at 2pm, just before I'm off to work. It 
gives a small energy kick, or it holds off the dopesickness when I've used up all 
my junk after a session. I get off work at 12, I'll take a hit right then. Taking H 
[heroin] after subs reduces the impact of the H, terrible.  
Forum user 'Smartbags' 
Like others, this user combined heroin with other opioids to manage the effects 
of withdrawal and cravings and to fit it in with work life. Other users mentioned 
similar patterns of use in relation to family and social obligations. 
From forum discussions, customers experiencing withdrawal symptoms, and 
looking for relief from them, emphasise rapid despatch and delivery as a valued 
quality in a vendor. This is evident from the heroin/opiate threads where 
discussions of withdrawal were common: 
Colour me slightly pissed. First of all, I adore [vendor] 0Bummer – he is the biz 
[business]. Well, he was meant to ship my stuff on Wednesday. He gets back to 
his house and sees my shipment sitting there. He'd forgotten. Right away he 
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pm'ed [messaged] me which I really like as vendors don't usually admit to 
mistakes. He said that because I am a regular customer I would be pleased 
with my bag (sounds like extras!) and he would send it UPS [parcel delivery] 
overnight guaranteed next day delivery. But nada came in the post today. So I 
will be [dope]sick for the rest of the week. I finished my heroin yesterday and it 
was VITAL that this shipment arrived. Yuck, feeling sick already. 0Bummer 
made an honest error and is trying to fix it. I'm not holding him responsible – I 
blame the tropical storm down here and UPS. 
Forum user ‘Nevertrustahippy23’ 
Many heroin users expressed the need to achieve a stable, predictable effect that 
would deal with their dopesickness (heroin withdrawal) and allow them to 
continue their social, familial and employment obligations without interference.  
For these users, the vagaries of the vendors and various national postal services 
becomes part of the material risk of withdrawal.  Vendors could recognise this 
and some forum users said they had prioritised orders for buyers who had told 
them they are going to experience withdrawal.   
These vendors are pretty sympathetic to us junkies and the dumb stress we 
have waiting for our junk 
Forum user Slaphappy 
Vendors taking on a customer service role helping users avoid withdrawal is in 
stark contrast to the dismissive attitude towards dopesickness displayed by 
dealers in contexts where users are highly marginalised (Bourgois, 1998), and 
the willingness of dealers in some offline markets to rip off weaker, irregular and 
addicted customers (Jacques, Allen, & Wright, 2014).  It suggests a very different 
power relationship where vendors are, to some extent, at the mercy of users’ 
evaluations of them, something they sought to manage.   
Presenting purity  
Purity took on three meanings in users’ accounts: it could mean a sense that the 
drug is in an uncontaminated state, that it is in an ideal state for achieving the 
desired effect, and to refer to the drug’s chemical strength. Vendors usually list 
claims about purity in the last sense; cocaine, for example, is sold as ‘pure, uncut, 
80%+’, ‘purity tested’, ‘Scott tested’ and mephedrone as ‘97% pure’.  Other 
listings make reference to general purity without making numerical claims. 
Cannabis listings feature more claims about effect and plant qualities with less 
focus on the strength of active agents in the drug. Other claims of implied purity 
are made by reference to region of production, such as Dutch MDMA or 
Colombian cocaine, or by brand (Lee, Battle, Soller, & Brandes, 2011).  Vendors 
also grade their products to sell to different markets, dealers and users, smokers 
and intravenous users. Heroin is offered by the same vendors in different grades, 
for example ‘potent’ or ‘extreme’. They also sell different types with 
characteristics suitable to injecting or smoking. 
Initially it seemed as if chemical strength and consistency is used as the main 
metric of purity. When examining threats to purity it became apparent that, for 
heroin users, effectiveness did not easily map on to the chemical purity of the 
drug. Heroin of lesser purity could give a better ‘rush’.  
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[Vendor] SilverLining's number 4 [heroin] is no great shakes in the rush stakes. 
It is meant to be very pure. It was creeper H which does not have the 
identifiable rush like the best black tar [heroin] or china white. Therefore I 
combine it with morphine, which gives a pleasant rush (it's my thing).  
Forum user ‘FreakBEat’ 
This highlighted how idea of purity as ‘close to the ideal’ could be separate from 
purity as chemical strength or uncontaminated. For cocaine and heroin 
particularly, users noted a practical difference between cutting as bulking out, 
and adulteration to enhance or change the high (Coomber, 1997a, 1997b). They 
also perceived an ethical distinction between different motives for adulteration. 
Adulteration could be seen as useful or as deceptive. When perceived as 
deceptive, users interpret adulteration as being used to mask the vendor bulking 
out the drug to increase profit and an attempt to give the false impression of 
potency. When seen as useful it could be interpreted as the vendor enhancing the 
drug’s effects in some way. That might be increasing the length of the high, or 
changing the shape of the high, for example, creating a longer and more sedating 
‘tail’ to the experience. 
Well it was yours truly and a few dudes trying out the coke yesterday. I 
gummed some first and the numbing slowly kicked in. We kept on with this 
until about 3am and we had about a g[gram] left which is not typical. Today: 
no stuffed nose, had a restful night, and it's a normal day on the road! My 
assessment is that this won't test as pure for cocaine as someone like [vendor] 
StraitOuttaTrumpton who's got the purest coke you can find but it is up there. 
Buy? God yeah! 
Forum user ‘Schnellman’ 
Adulteration could also involve changing how the drug looked or felt: making 
lower quality powder methamphetamine look like crystal, for example. These 
characteristics were taken to demonstrate the authenticity of the drug and the 
production process 
 They important meth from the USA but they don't use the lithium/ammonia 
'shake'n'bake' method or the racemic method – you get crank 
[methamphetamine] stuck into big white bits so it looks like crystallised d-
methamphetamine or Ice. They use the better iodine and red phosphorous 
method. British meth uses phosphonic acid which gives a cleaner end result. 
Forum user ‘HappyDaze’ 
As this forum quote illustrates, a range of experience and knowledge is used to 
assess purity. However, potency was not completely analogous to the drug's 
chemical purity. Potency might indicate the drug had been adulterated, as did 
absence of negative effects: 
It seemed potent, but I'm pretty sure that it seemed so potent because it was 
cut with some antihistamine or other sedative. Didn't really make me itchy or 
nauseous, which good dope always does. 
Forum user ‘Benzobeatz’ 
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In this and similar accounts there is a direct link drawn between genuine, rather 
than apparent, potency and negative effects. In other cases, risk is a measure of 
potency: the stronger the drug, the greater the danger. The positive association 
between risk and effectiveness has been noted in relation to pharmaceuticals as 
well as recreational drugs (E. Martin, 2006). Likewise, a heroin high that felt too 
‘clean’ could be taken as evidence that it is adulterated and ultimately less 
effective. On the other hand, many more sought the smooth, untroubled high as a 
sign of purity. Decorte (2001) suggests many users mistake side effects as signs 
of adulteration and so a high that feels pure is likely to be from a drug that is 
much less than pure. Different dynamics and expectations existed for different 
drugs. Heroin is expected to be higher purity than street heroin, but also to cost 
more. Cheap heroin is suspect as like to be cut. Cannabis is expected to be 
significantly cheaper for the quality. Many heroin users were willing to pay more 
for reliable quality. Heroin users adhered more to the idea that the drug has a set 
of consistent qualities that are hidden by adulteration, whereas cannabis users 
had a greater sense of the drug as multiple, and could perceive high chemical 
purity as working against effectiveness. 
Dosing and the user’s body 
The users’ embodiment – their awareness of the body as an instrument and 
mediator of experience - is the focus for several different kinds of knowledge 
which are used and shared. In relation to heroin, it is recognised in how the drug 
responded differently depending on the user’s tolerance: 
If your H is rubbish and you've not been doing opioids like oxy or subs you will 
have low tolerance. Take the right dope and a small dose, fifty to seventy-five 
milligrams, and you'll have a mid-range high. Stick to less than a hundred mgs 
until you're sure of how the H you have works on you. Take care if your 
tolerance depends on rubbish dope. It's about how your body handles it and 
you're the only one who knows that. 
Forum user 'Snarkfish' 
Tolerance was represented as an attribute of the user's body that they had to be 
aware of and both use to assess drug quality and properly titrate their use. It also 
is acknowledged in advice about dosing. The view that 'everyone is different' 
prevailed, and general rules of thumb are given out by users to advise on what 
might be expected at different doses. Users share advice on titration, discussing 
how to produce different kinds of effect with heroin using varying dosage and 
different injection and smoking techniques. 
Users advised others to test small amounts of heroin to gauge quality in relation 
to tolerance 
I expect you'd be okay taking one third of the bag, but it might make you sick if 
you have a low tolerance. In that case, best to snort a few bumps to test the 
strength. With a new batch I take small test shots or bumps. You won't waste 
much that way. 
Forum user ‘Minajatrois’ 
In this quote and many others there is an understanding of tolerance as 
embodied, and that the user’s own self-understanding is crucial to a successful 
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and safe drug use experience. Pleasure was embodied and could be experienced 
at different stages of drug consumption. It could come in preparation and/or 
anticipation, such as watching the flow of blood into the syringe when a vein is 
reached. A clean high is sought, corresponding to the drug's appearance of 
physical purity. A combination of colour, smell, texture and form signalled 
quality. In the case of heroin, users looked for various attributes: whether it 
‘crunched’ when cut, how it flaked, its colour, and when cooked whether it 
turned into a clear golden liquid. 
Is it lab grade? Maybe not quite there but certainly among the top gear and 
purest you can get. It's a beautiful white, when you put it in water it dissolves 
away completely, and it draws into the syringe nice and clear. Gives me that 
warm, pinned feel. 
Forum user ‘Fakepants’ 
Impurities were ‘dirt’, in the sense of matter out of place (Douglas, 1992). Dirt 
could include a physical residue left after dissolving heroin to inject it, or bodily 
reactions such as coughing and hacking. Side effects could be interpreted as dirt 
or could be taken as a sign of chemical purity. In this case there is a difference 
between more casual users - who saw side effects and comedowns as unwanted 
dirt contaminating the desired experience - and more regular and experienced 
users of cocaine and heroin, who saw side effects as a signal of potency and 
effectiveness.  
There is recognition of technique of injecting or smoking as part of the user’s 
embodied disposition. Users share these techniques and judgements to evaluate 
the desired qualities of different vendors’ products. Vendors make a greater 
contribution to these discussions, often defending the process by which they 
make claims about drug purity. This kind of knowledge is open to challenge. For 
example, vendors may suggest that critical users do not have the street 
experience to judge. Vendors and some more experienced forum users saw their 
role as policing some of the knowledge claims made about product quality and 
acted in the forum to shut down opposing claims.  
Craft and Chemical 
Drug testing is an expected part of market practice. Users of drugs purchased 
offline rely on craft and folk knowledge to evaluate quality (Decorte, 2001). They 
make judgements of quality based on colour, texture, smell, and structure. As 
mentioned earlier, in offline markets these judgements are often uncertain with 
limited opportunities for comparison and verification (Evrard et al., 2010).  We 
distinguish between empirical craft knowledge - that emphasises tacit 
judgements learned through direct interaction with the drug and its production 
and consumption process - and chemical-scientific knowledge that makes claims 
that are theoretically independent of users’ judgements. Scientific knowledge 
like that derived from chemistry claims a greater degree of abstraction and 
authority than craft knowledge, while craft knowledge emphasises its practical 
applicability. Both of these lay claim to higher status than ‘mere’ embodied 
experiential knowledge.  Expectations of the application of both judgements 
were explicit in many listings. Drugs were sold with the expectation of applied 
craft preparation, such as freebasing cocaine: 
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I sell clean, top alkaloid cocaine. Its purity is around 80%plus. It has made its 
journey from the jungles of Peru, via the Carib and finally the ports of Europe 
from where I send it round the globe. It's light on the nose and it's simple to 
make hot free-base coke. If you clean it with ammonia there will be no residue 
left behind. 
Vendor ‘ShakeIToff’ 
There is extensive evidence of craft and folk techniques being highly valued. 
Being able to assess weight visually is one: 
The coke turns up lumpy with some powder. Tastes, feels and smells like the 
real thing. I didn't weight it but a quick eyeball and it was one gram at least. 
You'll hear more when I get time off work to take it for a test run. 
Forum user ‘Kirknspock’. 
'Eyeballing', assessing weight and quality through sight alone, is a necessary skill 
when kitchen scales will not accurately measure at the scale of a gram and 
fractions of a gram.  
These folk testing techniques blurred into scientific-chemical ones so should not 
be seen as wholly separate. Some of the separation comes in the kind of 
equipment and language people assemble to make these judgements (for 
example, using beakers to create an ammonia wash) and this lends to it a more 
science-like air. 
Feedback from chemists is relied on: 
I'm a research chemist with the equipment and the training to test drug purity.  
I have bought different gear off the darknet for more than a year and a bit, 
good and bad. I have to say that [vendor] Moonface is the only one who's coke 
hit over ninety percent pure. 
Forum user ‘Fatlad’ 
The ability to use and interpret a test does not necessarily require theoretical 
knowledge. One forum user offered to have samples of cocaine tested at public 
labs in Europe and posted the results on the forum. This got round the problem 
of public drug testing facilities in many European countries only allowing for in-
person testing. The status of chemical knowledge was contested. For some the 
‘final word’ on a discussion of purity is that of those who use chemical tests. 
Others, such as a user running an independent cocaine testing service, stressed 
that lab tests only reveal the chemical makeup of that specific sample, not the 
vendor’s entire product line, and that a test would not reveal how the user would 
respond to the drug. Proper dose-testing procedures should still be followed. 
Despite the salience accorded to lab tests, from the discussions it is clear that the 
worth of the drug is assessed in its subjective uses that are in some cases at 
variance with its chemical purity. 
 There was a tension here between the subjective experience of using the drug 
and the objective knowledge derived from craft and chemical testing. What users 
were doing was employing these different kinds of knowledge to define the drug 
as coherent and stable. Tests, pill reports and dosage techniques were part of the 
drug assemblage. Users were aware that an effective drug had to be produced, 
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sometimes by adulteration. The ‘true’ drug, in the sense of the ideal, effective and 
predictable substance, then, is not always the chemically purest one and, in any 
case, many drugs are composed of several active substances.  A skilled vendor 
could produce the desired drug though judicious adulteration or purification. In 
this they acted like a producer in a taste culture, their ‘cooking’ culturally 
transforming the ‘raw’ drug into its true self (Vuolo, Uggen, & Lageson, 2014). 
Users constructed some drugs (including cocaine, ecstasy, and amphetamine) as 
more artificial and amenable to chemical testing. In contrast, cannabis is treated 
more as a fine wine, less amenable to scientific prodding and poking and with 
secrets open only to the experienced connoisseur. It is viewed as a drug that 
needed more experiential knowledge to judge, assessing the kind of the high and 
the subjective effects it produced. Overall the more risky the drug is perceived to 
be, the more potent it is thought to be, and the more testing is needed to verify 
its purity and quality. In those cases users relied more on chemical knowledge. In 
contrast, cannabis was presented as a drug that could only be evaluated through 
experiential knowledge and to some extent users resisted ideas of quality that 
relied on chemical testing of purity 
Discussion 
In common with other drug users, darknet users’ understandings of product 
quality depended on their experience, the purpose of use, and its context. Effects 
are generated in a practical, structured embodiment (Vitellone, 2015). Desired 
effects are set against judgements of safety and predictability (Sheridan & Butler, 
2010). The understanding of quality as potency (Reuter & Caulkins, 2004) is of 
keen interest to drug users (Reinarman, 2009) and features in public and 
scientific discussions of drug risk and control. However these questions are not 
just ones of achieving customer satisfaction. They are political, in the sense of 
being used to promote particular agendas and positions. Purity is presented as a 
coherent, testable attribute in policy and media discussions – whereas users find 
that purity is multiple (Duff, 2013). Claims about drug purity became a live 
political issue with the 2009 reclassification of cannabis in the UK. One argument 
put forward in favour of moving cannabis to a more restrictive classification was 
that the drug had changed, becoming more potent and increasing the risk of 
psychosis due to strains being bred with higher tetrahydrocannabinol content 
(Monaghan, 2014). In that debate, purity was reduced to, and equated with, 
danger (Di Forti et al., 2015; Office of National Drug Control Policy, 2004). Public 
health bodies promote the view that adulterants are the cause of adverse and 
unwanted effects (Harris, Forseth, & Rhodes, 2015). In the case of illicit drugs, 
both purity and impurity are therefore defined as drivers of harm (Scott, 
Caulkins, Ritter, Quinn, & Dietze, 2015). However, this is not a simple cause and 
effect relationship. An analysis of literature from the Europe and the USA show 
that changes in chemical purity are not strongly associated with opioid overdose 
deaths (Darke & Farrell, 2014).  
There are two implicit claims at work in discourse on drugs in the darknet that 
we have sought to open up. It is assumed that purity is the measure of a drug’s 
desirability and that darknet markets make purity transparent. We sought to test 
these two claims. There are three apparently coherent concepts around which 
users make judgements about product quality: purity, embodied experience, and 
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craft/chemical knowledge. We have shown how each is enacted and shared. 
Users’ ability to integrate different forms of knowledge about drug quality is key 
to successful judgements about product worth and assembling the drug as a 
usable, culturally tangible object. Users’ ideas of desirable effects depended on 
the purpose for which they were using the drug.  Reliability is prized both in 
terms of the drug acting consistently and being delivered on time. Users establish 
discussions about quality as their establishment of their position as drug users.  
Transparency is not automatically produced by the market and vendor listings, 
nor reducible to any single attribute of the drug such as its chemical strength or 
degree of adulteration. Judgements of quality are co-produced between users 
and vendors. The darknet market creates a setting where drug users discuss 
product value and quality. They use the forum to compare notes between 
vendors and between batches of product. What is novel is the ability of users to 
employ different kinds of knowledge to assess drug quality. The process of 
judgement is a key part of assembling the drug and its context (Duff, 2011). 
Users had preferred methods to do so: chemical tests, 'taste' abilities, and 
comparing notes with others on and offline. They balanced various factors from 
expected to actual effect to comedown and how it interacts with other drugs.  
Most notable is the dissemination of craft and chemical expert knowledge. This 
has always been part of the dealer armoury and is now disseminated further by 
expert buyers acting as key knowledge nodes. Developments in technology allow 
for technical assays to be made. This adds another kind of knowledge into the 
assessments of drugs. It is in contrast to how scientific knowledge has been seen 
in other contexts as working against users' own concepts of drug use and 
experience (Letcher, 2007). It is made explicit in how drugs are sold, with 
different grades of some drugs offered by the same vendor at different rates.  
We have argued in this paper that the different capacities of darknet users allow 
rapid assessment and comparison of chemical purity. Darknet users integrate 
this knowledge systematically into their own drug use. Referring to chemical 
knowledge as the final word changes their understanding of what a ‘good’ and a 
‘bad’ batch is and encourages users to focus more on purity. It also gives them a 
consistent, high status language with which to describe their drug use. Chemical 
purity, though highly valued, is not the sole dominant evaluative standard. It 
takes its place with other kinds of knowledge and dispositions towards drug 
consumption. Dealers and users may not value purity directly but instead the 
combination of adulterants that create specific effects (Coomber, 1997b), lasting 
effects which can be combined with work or social life, or the readiness of the 
drug to be repurposed into another form. Subjective potency may, then, only be 
loosely related to purity.  This may be one reason why users find pharmaceutical 
heroin unsatisfying compared to street heroin (Vitellone, 2003). We do not want 
to overemphasise the distinction between street and darknet markets. Many of 
our interviewees still bought on the street market and some of the customer 
orientation identified in the darknet is also present in the street market, where 
dealers compete with each other and offer incentives to users to switch 
(Coomber, 2006). In contrast to research with users who purchase drugs in some 
offline markets, our research has shown darknet market users to be more 
confident to probe and question claims made about quality by vendors. Vendors 
are pushed to make and justify quality claims. This indicates a shift in user 
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comportment and power. They are employing these kinds of knowledge to 
evaluate drug quality and sharing this knowledge with peers in the market 
forum.    
We have confirmed and elaborated on previous research that has explored the 
operation and shape of the darknet markets, who uses them and their 
motivations (Barratt et al., 2014; Buxton & Bingham, 2015; J. Martin, 2014; Van 
Hout & Bingham, 2014). Our study has illuminated the ways users produce the 
markets through their sharing of information and evaluation of quality using 
various knowledge forms. These can be thought of as examples of peer harm 
reduction (Parkin, 2013; Parkin & Coomber, 2009).  For many users, discussions 
about quality embedded harm reduction as a normal practice. This is not 
confined to stereotypically recreational drugs such as cannabis and ecstasy. 
There is a lively discussion around heroin, opioids and methamphetamine on the 
forum. Use of these drugs is typically associated with chaotic lifestyles. However 
many forum users were in relatively stable circumstances, including in 
employment. The 'healthy heroin user' has been identified in other studies 
(Shewan & Dalgarno, 2005).  Buying heroin on the darknet had the advantage of 
fitting in well with their lifestyle and they looked for qualities in the product and 
delivery of it that would fit with their social obligations.  
Users can benefit from more systematic sharing of knowledge about product 
quality and risk, which the darknet partly answers. The sharing of experiences 
and different forms of knowledge on the darknet forum points to a potential for 
harm reduction:  different kinds of knowledge are employed to assess the quality 
of various products. Users share peer harm reduction advice covering dose 
titration, integrating or avoiding polydrug use, interpreting side effects and 
testing purity. Inconsistencies and other problems can be reported quickly and 
information about effective and safer production and consumption techniques 
are shared.  The next step is whether public health initiatives can convincingly 
engage with forums like this in promoting harm reduction.  
Possibilities for doing this are:  
- Using cryptomarket forums to distribute harm reduction advice and 
promote services. 
- Establishing a presence on market forums to comment on harm reduction 
topics as they arise and validate users’ own peer practices. 
- Providing ways for vendors to add harm reduction advice to their listings. 
- Posting drug alerts on related forum threads. 
- Using trusted, encrypted communications systems to provide secure, 
confidential advice to users. 
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